Floatz logo

Rimonabant

Carotid Artery Plaque

SanofiSmall moleculePhase 3Dormant
CC
45/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
30/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Carotid Artery Plaque cohort.

Asset / SponsorPhaseRating
Plavix
Asan Medical Center
Phase 4BB
Lipitor
Columbia University
Phase 4BB
EPHEDRINE, ANHYDROUS
University Hospital, Clermont-Ferrand
Phase 4BB
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril
Asan Medical Center
Phase 4BB
Acetylsalicylic Acid
Asan Medical Center
Phase 4BB

View all 27 →

Same molecule, other indications

Rimonabant is also rated in:

obesity disorderDormant
CCC
Indicative ·
51 / 100
View asset →
inherited lipid metabolism disorderDormant
CCC
Indicative ·
50 / 100
View asset →
type 2 diabetes mellitusDormant
CCC
Indicative ·
50 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →